PRESS RELEASE published on 11/02/2023 at 13:30, 2 years 3 months ago Jaguar Health Enters Exclusive Crofelemer Revenue Sharing License and Commercialization Agreement with Quadri Pharmaceuticals Store for Rare Intestinal Failure Diseases in Middle East Markets
PRESS RELEASE published on 11/01/2023 at 13:30, 2 years 3 months ago Issuance of New US Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
PRESS RELEASE published on 10/30/2023 at 13:30, 2 years 3 months ago Magdalena Biosciences, a Joint Venture between Jaguar Health and Filament Health, Receives Second Tranche of Funding from One Small Planet
PRESS RELEASE published on 10/26/2023 at 14:30, 2 years 4 months ago Jaguar Health to Present November 1st at Emerging Growth Conference
PRESS RELEASE published on 10/23/2023 at 14:30, 2 years 4 months ago Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications
PRESS RELEASE published on 10/19/2023 at 14:30, 2 years 4 months ago Independent Study Conducted at Boston Children's Hospital, Harvard Medical School, Shows Potential Utility of Jaguar Health's Crofelemer for Treatment of MVID, a Rare Childhood Disease
PRESS RELEASE published on 10/18/2023 at 14:30, 2 years 4 months ago Napo Pharmaceuticals to Exhibit at the October 25-28 Annual Association of Nurses in AIDS Care (ANAC) Conference for Mytesi, the Company’s FDA-Approved Prescription Drug
PRESS RELEASE published on 10/12/2023 at 14:30, 2 years 4 months ago Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum
PRESS RELEASE published on 10/10/2023 at 14:30, 2 years 4 months ago Jaguar Animal Health Exhibiting at October 12-14 VCS Annual Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
PRESS RELEASE published on 09/28/2023 at 14:30, 2 years 5 months ago Jaguar Health to Present October 3 at LD Micro's Main Event Investor Conference, and on October 5 at the Global Capital Network Investor Conference
Published on 02/28/2026 at 10:00, 11 hours 29 minutes ago Storm Exploration Issues Shares to Eabametoong First Nation
Published on 02/28/2026 at 03:00, 18 hours 29 minutes ago Dynamite Blockchain Announces Change in Auditor
Published on 02/28/2026 at 02:00, 19 hours 29 minutes ago Empress Reports 2025 Year End Financial Results
Published on 02/28/2026 at 00:10, 21 hours 19 minutes ago Algo Grande Copper Closes Oversubscribed $6.52 Million Financing and Strengthens Board at AGM
Published on 02/28/2026 at 21:00, 29 minutes ago CARLSBERG MAKES EVERY FAN FEEL PART OF MATCHDAY WITH BRITISH SIGN LANGUAGE RENDITION OF 'YOU'LL NEVER WALK ALONE'
Published on 02/28/2026 at 19:15, 2 hours 14 minutes ago Athletes from Sweden and the Netherlands Win Medals at the Olympic Winter Games Milano Cortina 2026 as Team TCL Ambassador Reaches the Podium
Published on 02/28/2026 at 16:55, 4 hours 34 minutes ago CGTN: How China's path of democracy safeguards people's rights and interests
Published on 02/28/2026 at 11:12, 10 hours 17 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 02/27/2026 at 23:00, 22 hours 29 minutes ago Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Published on 02/27/2026 at 18:02, 1 day 3 hours ago AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion
Published on 02/27/2026 at 17:45, 1 day 3 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2025
Published on 02/27/2026 at 17:45, 1 day 3 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026
Published on 02/27/2026 at 08:45, 1 day 12 hours ago Air Liquide and Holcim sign an agreement to decarbonize cement production with a carbon capture project in Belgium
